[Inhibition of gastric acid secretion and motility with trospium chloride].

The present study demonstrated a significant inhibition of gastric acid secretion and gastric motility by parenteral and oral application of trospiumchloride. Oral application of a dose inhibiting gastric acid secretion was not associated with the known side effects of anticholinergic therapy like tachycardia, reduction of salivary secretion and impairment of visual accommodation.

RCT Entities:   Population Interventions Outcomes